Minimally Invasive Surgery Staging for Advanced Stomach Cancer
Part of Cancer, Digestive system clinical trials.
This trial tests whether a minimally invasive camera-guided surgical procedure (laparoscopy) can better detect hidden cancer spread in patients with advanced stomach cancer. The goal is to help doctors plan the best treatment and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Biopsy-confirmed adenocarcinoma (cancer) of the stomach or where the stomach meets the esophagus
- Advanced cancer stage (T3/T4a with lymph node involvement) confirmed by imaging scans
- Age 18–75 years in generally good health, able to tolerate surgery and anesthesia
- Lab results available for HER2, MMR, PD-L1, and Claudin 18.2 (molecular markers)
- No evidence of cancer spread to the peritoneum (lining around organs) on imaging, and no other active cancers
- Expected survival of at least 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new surgical technique to remove the entire stomach using small incisions (laparoscopy). The goal is to see if this method is safe and feasible for patients with stomach cancer that hasn't spread, potentially offering a less invasive option.
This trial tests if surgery to remove visible cancer in the belly combined with heated chemotherapy placed directly into the abdomen can help people with stomach cancer that has spread to the lining of the belly. It is for patients who are well enough to undergo major surgery and meet specific health requirements.
This trial compares two types of minimally invasive surgery to remove stomach cancer that has grown into the stomach wall but has not spread. The goal is to see if using a robot gives better recovery and results than standard laparoscopic (keyhole) surgery.
This trial tests a new technique that uses a special dye to highlight the first lymph nodes where stomach cancer might spread, allowing surgeons to remove only the necessary nodes during surgery. The goal is to reduce side effects while still effectively treating the cancer.
This trial tests a minimally invasive surgery for stomach cancer that has spread to lymph nodes near the main blood vessels (para-aortic area). The surgery is done after a combination of chemotherapy and immunotherapy to shrink the tumor. It aims to see if this approach is safe and effective.
This trial is testing a combined approach using two types of endoscopy (a tube with a camera) along with minimally invasive surgery to treat early-stage stomach cancer. The goal is to remove the cancer with less impact on your body compared to standard surgery.
Hear when a new Gastric Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.